Free Trial

INVO Bioscience (INVO) Insider Trading & Ownership

INVO Bioscience logo
$0.80
+0.05 (+6.68%)
(As of 11/1/2024 ET)

INVO Bioscience (NASDAQ:INVO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.50%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$129,656.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get INVO Insider Trade Alerts

Want to know when executives and insiders are buying or selling INVO Bioscience stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INVO Insider Buying and Selling by Quarter

INVO Bioscience Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/1/2022Andrea GorenCFOBuy2,631$19.00$49,989.00  
6/1/2022Matthew K SzotDirectorBuy723$19.00$13,737.00  
6/1/2022Michael Jos. CampbellCOOBuy526$19.00$9,994.00  
6/1/2022Steve ShumCEOBuy2,944$19.00$55,936.00  
(Data available from 1/1/2013 forward)

INVO Insider Trading Activity - Frequently Asked Questions

The list of insiders at INVO Bioscience includes Andrea Goren, Matthew K Szot, Michael Jos. Campbell, and Steve Shum. Learn more on insiders at INVO.

3.50% of INVO Bioscience stock is owned by insiders. Learn more on INVO's insider holdings.

INVO Bioscience Key Executives

  • Mr. Steven M. Shum (Age 53)
    CEO & Director
    Compensation: $201.88k
  • Mr. Andrea  GorenMr. Andrea Goren (Age 57)
    Chief Financial Officer
    Compensation: $173.75k
  • Mr. Michael Jos. Campbell (Age 66)
    COO & VP of Business Development
    Compensation: $220k
  • Mr. Bojan Mitrovic Ph.D.
    Director of Sales US
  • Mr. Robert Joseph Bowdring Jr. (Age 66)
    Treasurer & Secretary
  • Ms. Terah Krigsvold
    Controller


This page (NASDAQ:INVO) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners